Barinthus Biotherapeutics. (BRNS) Q4 2023 Earnings

22MarExpected
Q2 2023
Q3 2023
Q4 2023
-0.62
-0.56
-0.51
-0.45

Details

Expected EPS
-0.5
Actual EPS
-0.45
Surprise EPS
0.05
Surprise Percent
+10%

Description

Barinthus Biotherapeutics. (BRNS) has reported earnings of -0.45 per share for Q4 2023.

0 Comments

Share your thoughts